Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Current Assets (2019 - 2025)

Historic Current Assets for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to $277.6 million.

  • Pharming's Current Assets fell 162.73% to $277.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $277.6 million, marking a year-over-year decrease of 162.73%. This contributed to the annual value of $278.4 million for FY2024, which is 1198.13% down from last year.
  • Per Pharming's latest filing, its Current Assets stood at $277.6 million for Q3 2025, which was down 162.73% from $245.8 million recorded in Q2 2025.
  • Pharming's 5-year Current Assets high stood at $316.3 million for Q4 2023, and its period low was $251770.9 during Q4 2021.
  • Over the past 5 years, Pharming's median Current Assets value was $266.1 million (recorded in 2023), while the average stood at $226.2 million.
  • In the last 5 years, Pharming's Current Assets plummeted by 9989.59% in 2022 and then skyrocketed by 11564660.38% in 2023.
  • Over the past 5 years, Pharming's Current Assets (Quarter) stood at $251770.9 in 2021, then soared by 110119.26% to $277.5 million in 2022, then grew by 14.0% to $316.3 million in 2023, then fell by 11.98% to $278.4 million in 2024, then fell by 0.3% to $277.6 million in 2025.
  • Its Current Assets was $277.6 million in Q3 2025, compared to $245.8 million in Q2 2025 and $214.1 million in Q1 2025.